Skip to content
Open access

Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis.

Aug 2026 · Journal of Affective Disorders · Vol 414, pp. 122406 · 0 citations · 41 references
Medicine

Abstract

INTRODUCTION Major depressive disorder (MDD) is highly prevalent and often treatment-resistant. Accelerated intermittent theta burst stimulation (aiTBS) is a promising intervention for treatment-resistant depression (TRD), though outcomes vary. Personality traits have been examined in relation to rTMS outcomes, yet their role in aiTBS remains underexplored. This pooled individual-patient-data analysis of two randomized, sham-controlled trials examined associations between baseline Temperament and Character Inventory (TCI) traits and one-week symptom change, and whether they differed by condition.

Methods

The left dorsolateral prefrontal cortex was targeted for 20 sessions over 4 days. Personality was assessed with the TCI, depression severity with the 17-item Hamilton Depression Rating Scale (HDRS-17). TCI-symptom-change associations were examined with a robust linear mixed-effects model, adjusting for age, gender, repeated measurements, and study membership.

Results

104 participants were included (M/F 45/59; mean age 40.9 ± 12.7; active/sham 50/54). The model yielded a Time × Novelty Seeking interaction (β = -1.70, p = 0.021): higher baseline Novelty Seeking was associated with faster symptom reduction, without a between-arm difference. However, the interaction did not survive Holm correction across 14 trait-interaction tests (adjusted p = 0.294) and is therefore exploratory. No other interaction reached the uncorrected threshold.

Conclusions

Higher baseline Novelty Seeking showed a nominal association with faster symptom reduction, without a difference between active and sham conditions. Because it did not survive multiplicity correction and was not reproduced in within-arm analyses, it is preliminary and may reflect contextual or nonspecific processes. Independent replication is required before temperament assessment can be clinically informative.

Read PDF

Similar papers

Aug 2026

Back to gut feelings. Latent class analysis of daily perceived health variations identifies later responses to antidepressant treatment.

Major depressive disorder (MDD) is a prevalent and disabling condition, yet predicting individual response to antidepressants remains difficult. Traditional symptom-based assessments, typically conducted weeks apart, may miss early and dynamic changes. Daily self-reported measures of wellbeing dimensions, particularly...

L. Di Lodovico, C. Westphalen, Chloé Tezenas-du-Montcel et al. · 0 citations
Open access Sep 2026

489. Task-based fMRI investigation of neural changes following acceptance and commitment therapy in major depressive disorder

Abstract Background Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric condition worldwide, and a substantial proportion of patients fail to achieve full remission with antidepressant pharmacotherapy or cognitive behavioral therapy (CBT). Acceptance and Commitment Therapy (ACT), a third-wav...

S. Lee, S. W. Lee, S. Kim et al. · 0 citations
Open access Jan 2026

Sensory Processing Profiles in Depression: Evidence of Dynamic Changes and Clinical Correlates Over 3 Months

These findings support the relevance of sensory traits as potential clinical markers and therapeutic targets and suggest personalized interventions addressing sensory processing may contribute to improved treatment outcomes.

A. Paquet, Lucia Fiegl, B. Plansont et al. · 1 citation
Open access Sep 2026

655. Toward a brief, sensitive tool to assess depressive symptom outcomes in research and clinical practice: lessons from the RECOVER trial

Abstract Background In RECOVER, a 12-month, double-blind, randomized, controlled trial (RCT) comparing active versus sham adjunctive vagus nerve stimulation (VNS) in persons with markedly treatment-resistant depression (mTRD), total scores on the Quick Inventory of Depressive Symptomology–Clinician (QIDS-C) and –Self-R...

A. Rush, H. Sackeim, Y.-C. Lee et al. · 0 citations
Open access Sep 2026

Right DLPFC repetitive transcranial magnetic stimulation in women with borderline personality disorder: A double-blind randomized sham-controlled trial.

BACKGROUND Borderline personality disorder (BPD) is characterized by emotional dysregulation and high rates of suicidal and self-harming behavior, while effective treatments remain limited. This study evaluated short- and long-term effects of right dorsolateral prefrontal cortex (DLPFC) rTMS in a double-blind, sham-con...

M. Horký, P. Bartys, Martin Jáni et al. · 0 citations
Sep 2026

Efficacy of tDCS-primed iTBS in major depressive disorder: A randomized, sham-controlled trial with exploratory resting motor threshold analyses.

BACKGROUND Intermittent theta burst stimulation (iTBS) is a promising treatment for major depressive disorder (MDD), yet inter-individual variability remains a challenge. Cathodal transcranial direct current stimulation (tDCS) is hypothesized to "prime" the cortex via homeostatic metaplasticity, potentially enhancing t...

Qin Qin, Ying-Ying Zhao, Shi-Bei Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.